Article
New York - Adjuvant therapy with a macrophage-activating growth factor appears to prolong survival in high-risk melanoma, Lynn E. Spitler, M.D., said.
Tips and Tricks for Successful Practice Management with Leon Kircik, MD
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Glynis Ablon, MD, on Getting Involved in Clinical Trials
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
The Future of Pediatric Care at MOPD
Study Highlights Image-Guided Superficial Radiation Therapy as a Viable First-Line Treatment for Nonmelanoma Skin Cancer